Short communication: Transmitted drug resistance and molecular epidemiology in antiretroviral naive HIV type 1-infected patients in Rhode Island
- PMID: 20954831
- PMCID: PMC3048815
- DOI: 10.1089/aid.2010.0198
Short communication: Transmitted drug resistance and molecular epidemiology in antiretroviral naive HIV type 1-infected patients in Rhode Island
Abstract
Transmission of HIV-1 drug resistance has important clinical and epidemiological consequences including earlier treatment failure and forward transmission of resistance strains in high-risk groups. To evaluate the prevalence and molecular epidemiology of transmitted drug resistance in Rhode Island, we collected genotypic, demographic, clinical, and laboratory data from treatment-naive individuals presenting to the largest outpatient HIV clinic in the state from January 2007 to November 2007. Sequences from 35 treatment-naive individuals were available, 83% of whom were men who had sex with men (MSM). All sequences were HIV-1 subtype B. Drug resistance mutations were identified in 7/35 [20%; 95% confidence interval (CI), 0.08-0.37] patients, six of whom had K103N. Two phylogenetic transmission clusters were found, involving 17% (6/35) of individuals, three in each cluster. We did not find an association between belonging to a cluster and age, gender, AIDS-defining illness, CD4 cell count, or viral load. Drug resistance mutations were more commonly observed in transmission clusters (p = 0.08). Individuals in one cluster all had K103N and were MSM who had attended local bathhouses. Individuals forming clusters were significantly more likely to have visited a bathhouse compared to nonclusters (p = 0.02). The prevalence of transmitted drug resistance in Rhode Island is high, further justifying genotypic testing on presentation to care and prior to treatment initiation. Molecular epidemiological analysis and association of resistance with phylogenetic networks using data obtained for clinical purposes may serve as useful tools for the prevention of drug resistance transmission and for contact tracing.
Figures
Similar articles
-
Primary drug resistance and transmission analysis of HIV-1 in acute and recent drug-naïve seroconverters in Singapore.HIV Med. 2009 Jul;10(6):370-7. doi: 10.1111/j.1468-1293.2009.00698.x. Epub 2009 Mar 11. HIV Med. 2009. PMID: 19490177
-
HIV type 1 subtype diversity and drug resistance among HIV type 1-infected Kenyan patients initiating antiretroviral therapy.AIDS Res Hum Retroviruses. 2009 Dec;25(12):1211-7. doi: 10.1089/aid.2009.0007. AIDS Res Hum Retroviruses. 2009. PMID: 19954302
-
Antiretroviral treatment failure, drug resistance, and subtype diversity in the only pediatric HIV clinic in Rhode Island.Clin Infect Dis. 2015 May 1;60(9):1426-35. doi: 10.1093/cid/civ058. Epub 2015 Jan 30. Clin Infect Dis. 2015. PMID: 25637585 Free PMC article.
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
-
HIV-1 Non-Group M Strains and ART.Viruses. 2023 Mar 17;15(3):780. doi: 10.3390/v15030780. Viruses. 2023. PMID: 36992488 Free PMC article. Review.
Cited by
-
Short communication: new HIV infections at Southern New England academic institutions: implications for prevention.AIDS Res Hum Retroviruses. 2013 Jan;29(1):25-9. doi: 10.1089/AID.2012.0130. Epub 2012 Jul 25. AIDS Res Hum Retroviruses. 2013. PMID: 22724920 Free PMC article.
-
Phylogenetic and geospatial evaluation of HIV-1 subtype diversity at the largest HIV center in Rhode Island.Infect Genet Evol. 2014 Dec;28:358-66. doi: 10.1016/j.meegid.2014.03.027. Epub 2014 Apr 8. Infect Genet Evol. 2014. PMID: 24721515 Free PMC article.
-
Defining HIV-1 transmission clusters based on sequence data.AIDS. 2017 Jun 1;31(9):1211-1222. doi: 10.1097/QAD.0000000000001470. AIDS. 2017. PMID: 28353537 Free PMC article.
-
Characterizing HIV transmission networks across the United States.Clin Infect Dis. 2012 Oct;55(8):1135-43. doi: 10.1093/cid/cis612. Epub 2012 Jul 10. Clin Infect Dis. 2012. PMID: 22784872 Free PMC article.
-
Interrupting transmission of HIV and other sexually transmitted infections in Rhode Island.Med Health R I. 2012 Aug;95(8):241-4. Med Health R I. 2012. PMID: 22970465 Free PMC article. No abstract available.
References
-
- Clavel F. Hance AJ. HIV drug resistance. N Engl J Med. 2004;350:1023–1035. - PubMed
-
- Deeks SG. Treatment of antiretroviral-drug-resistant HIV-1 infection. Lancet. 2003;362:2002–2011. - PubMed
-
- Boyd AC. Herzberg EM. Marshall MM, et al. Antiretroviral drug resistance among treatment-naive HIV-1-infected persons in Washington, D.C. AIDS Patient Care STDS. 2008;22:445–448. - PubMed
-
- Eshleman SH. Husnik M. Hudelson S, et al. Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection. AIDS. 2007;21:1165–1174. - PubMed
-
- Grant RM. Hecht FM. Warmerdam M, et al. Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA. 2002;288:181–188. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials